TY - JOUR
T1 - Association of paternal age with perinatal outcomes between 2007 and 2016 in the United States
T2 - Population based cohort study
AU - Khandwala, Yash S.
AU - Baker, Valerie L.
AU - Shaw, Gary M.
AU - Stevenson, David K.
AU - Lu, Ying
AU - Eisenberg, Michael L.
N1 - Publisher Copyright:
© 2018 Published by the BMJ Publishing Group Limited.
PY - 2018
Y1 - 2018
N2 - Objective: To evaluate the impact of advanced paternal age on maternal and perinatal outcomes in the United States. Design: Retrospective, population based cohort study. Setting: US. Population: 40 529 905 documented live births between 2007 and 2016. Main outcome measures: Primary perinatal outcomes were gestational age, birth weight, Apgar score at five minutes, admission to a neonatal intensive care unit, need for postpartum antibiotics, and seizures. Primary maternal outcomes were gestational diabetes and pre-eclampsia. Secondary outcome was the number of preventable perinatal events. Results: Higher paternal age was associated with an increased risk of premature birth, low birth weight, and low Apgar score. After adjustment for maternal age, infants born to fathers aged 45 years or older had 14% higher odds of premature birth (odds ratio 1.14, 95% confidence interval 1.13 to 1.15), independent of gestational age, and 18% higher odds of seizures (1.18, 0.97 to 1.44) compared with infants of fathers aged 25 to 34 years. The odds of gestational diabetes was 34% higher (1.34, 1.29 to 1.38) in mothers with the oldest partners. 13.2% (95% confidence interval 12.5% to 13.9%) of premature births and 18.2% (17.5% to 18.9%) of gestational diabetes in births associated with older fathers were estimated to be attributable to advanced paternal age. Conclusions: Advanced paternal age is associated with negative effects on both mothers and offspring. Given the relatively low prevalence of advanced paternal age in the US, population level impacts are currently modest. Nevertheless, as advanced paternal age has doubled in the US over the past generation, further investigation is warranted of the impact on birth outcomes and public health.
AB - Objective: To evaluate the impact of advanced paternal age on maternal and perinatal outcomes in the United States. Design: Retrospective, population based cohort study. Setting: US. Population: 40 529 905 documented live births between 2007 and 2016. Main outcome measures: Primary perinatal outcomes were gestational age, birth weight, Apgar score at five minutes, admission to a neonatal intensive care unit, need for postpartum antibiotics, and seizures. Primary maternal outcomes were gestational diabetes and pre-eclampsia. Secondary outcome was the number of preventable perinatal events. Results: Higher paternal age was associated with an increased risk of premature birth, low birth weight, and low Apgar score. After adjustment for maternal age, infants born to fathers aged 45 years or older had 14% higher odds of premature birth (odds ratio 1.14, 95% confidence interval 1.13 to 1.15), independent of gestational age, and 18% higher odds of seizures (1.18, 0.97 to 1.44) compared with infants of fathers aged 25 to 34 years. The odds of gestational diabetes was 34% higher (1.34, 1.29 to 1.38) in mothers with the oldest partners. 13.2% (95% confidence interval 12.5% to 13.9%) of premature births and 18.2% (17.5% to 18.9%) of gestational diabetes in births associated with older fathers were estimated to be attributable to advanced paternal age. Conclusions: Advanced paternal age is associated with negative effects on both mothers and offspring. Given the relatively low prevalence of advanced paternal age in the US, population level impacts are currently modest. Nevertheless, as advanced paternal age has doubled in the US over the past generation, further investigation is warranted of the impact on birth outcomes and public health.
UR - http://www.scopus.com/inward/record.url?scp=85055852300&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055852300&partnerID=8YFLogxK
U2 - 10.1136/bmj.k4372
DO - 10.1136/bmj.k4372
M3 - Article
C2 - 30381468
AN - SCOPUS:85055852300
SN - 0959-8146
VL - 363
JO - British Medical Journal
JF - British Medical Journal
M1 - k4372
ER -